Development of new drug delivery systems is a central means for optimization of drug therapy. <br><br>When anti-infectives are concerned, new dosage forms may not only facilitate effective microbiological activity, reduction in adverse drug effects and enhanced adherence, but also promote preservation of use of anti-infectives, an essential goal in light of the global threat of emergence of antimicrobial-resistant pathogens and the continuously declining rate of development of new antimicrobials
การแปล กรุณารอสักครู่..
